Cannabis Remains Schedule I Despite 38 State Programs, Federal Clash Persists

Federal Classification Under the Controlled Substances Act

Cannabis is classified as a Schedule I substance under 21 U.S.C. § 812, the same category as heroin and LSD, meaning the federal government considers it to have no accepted medical use and high abuse potential. This classification hasn't changed since the Controlled Substances Act took effect in 1970, despite multiple petitions to the Drug Enforcement Administration for rescheduling.

The DEA published a Notice of Proposed Rulemaking in May 2024 proposing to move cannabis to Schedule III. No final rule has been issued. Until a final rule takes effect, cannabis possession, cultivation, and distribution remain federal crimes under 21 U.S.C. § 841, punishable by up to five years in prison for first-time offenders and up to life imprisonment for large-scale operations.

The Department of Justice has issued guidance memos—most notably the 2013 Cole Memo, rescinded in 2018—advising federal prosecutors to deprioritize enforcement in states with strong regulatory frameworks. That guidance carries no legal force. It can be withdrawn at any time.

State-Level Legalization Does Not Override Federal Law

Thirty-eight states and the District of Columbia have legalized cannabis for medical or adult use, but state law can't nullify federal criminal statutes under the Supremacy Clause of the U.S. Constitution. Operators licensed by California, Colorado, Michigan, and other states remain subject to federal prosecution, asset forfeiture, and criminal penalties.

Federal law enforcement retains jurisdiction to prosecute cannabis offenses on federal property, across state lines, and in any state regardless of local law. The Bureau of Alcohol, Tobacco, Firearms and Explosives prohibits cannabis users from purchasing firearms under 18 U.S.C. § 922(g)(3). Immigration authorities can deny naturalization or deport noncitizens for cannabis-related conduct even when state-legal.

State licensing provides no safe harbor from federal criminal liability; operators remain vulnerable to prosecution, particularly if they trigger federal enforcement priorities such as diversion to minors or interstate trafficking.

280E Tax Penalties and Banking Restrictions

Internal Revenue Code § 280E prohibits businesses trafficking in Schedule I or II substances from deducting ordinary business expenses, resulting in effective tax rates of 70% or higher for cannabis operators. This applies to all federally illegal cannabis businesses, including state-licensed dispensaries and cultivators.

The IRS has consistently applied 280E in audits and Tax Court cases, disallowing deductions for rent, payroll, marketing, and other costs. Only cost of goods sold—limited to direct production costs—can be deducted. The Ninth Circuit upheld 280E's application to state-legal cannabis in Olive v. Commissioner, 139 T.C. 19 (2012), and subsequent cases have followed that precedent.

Banking remains restricted because the Bank Secrecy Act requires financial institutions to file Suspicious Activity Reports for transactions involving proceeds of illegal activity. Most banks decline to serve cannabis clients to avoid potential money-laundering charges under 18 U.S.C. § 1956, forcing operators to conduct business in cash. The SAFE Banking Act, which would create a safe harbor for banks serving state-legal cannabis businesses, has passed the House seven times but hasn't cleared the Senate.

Congressional Inaction and Rescheduling Timeline

No federal cannabis legalization bill has advanced to a floor vote in either chamber of Congress, and the DEA's proposed rescheduling to Schedule III remains pending with no final rule date announced. The rescheduling NPRM published in the Federal Register on May 21, 2024 (Docket No. DEA-407) opened a 60-day comment period that closed in July 2024.

The DEA must review over 43,000 public comments before issuing a final rule. Administrative law experts estimate a final rule could take 12 to 24 months from the close of the comment period. Schedule I status is likely to persist through at least mid-2026. Even if rescheduled to Schedule III, cannabis would remain federally controlled, and cultivation or distribution without DEA registration would remain a federal crime.

Legislative proposals including the SAFE Banking Act, the STATES Act, and the MORE Act have stalled in committee or failed to advance in the Senate. No comprehensive federal legalization framework has cleared either chamber.

What Operators and Consumers Should Know

State-legal cannabis operators face ongoing federal legal risk, tax burdens, and banking exclusion until Congress or the DEA changes federal law. Operators should monitor the DEA rescheduling docket and maintain compliance with state regulations to minimize federal enforcement risk, though compliance doesn't eliminate exposure.

Key operational risks include:

• Federal prosecution under 21 U.S.C. § 841 for cultivation, distribution, or possession with intent to distribute
• Asset forfeiture under 21 U.S.C. § 881 for property used in drug trafficking
• 280E tax liability resulting in 70%+ effective tax rates
• Banking exclusion forcing cash-only operations and increasing security and compliance costs
• Immigration consequences for noncitizens, including inadmissibility and deportation

Consumers in state-legal markets face minimal federal enforcement risk for personal possession, but federal law prohibits possession on federal property, including national parks, military bases, and federally subsidized housing. Employers can terminate employees for cannabis use even in legal states. Federal contractors must maintain drug-free workplace policies under the Drug-Free Workplace Act.

For full background on this issue, see the CannIntel topic hub on federal cannabis legalization.

The next major signal: the DEA's final rule on rescheduling, expected no earlier than Q3 2026. Until then, the federal-state legal conflict remains unresolved.